AFWM
HAE icon

Abich Financial Wealth Management’s Haemonetics HAE Stock Holding History

Abich Financial Wealth Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8
Closed -$662 – 593
2024
Q2 		$662 Buy
+8
New +$704 ﹤0.01% 683

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Abich Financial Wealth Management's HAE Position: Q3 2024 in Review

Abich Financial Wealth Management sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 8 shares — an estimated $662 sold.

Abich Financial Wealth Management first reported a position in HAE in Q2 2024 and held it in 1 quarter. The position peaked at $662 in Q2 2024. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Abich Financial Wealth Management reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Abich Financial Wealth Management sold 8 Haemonetics shares in Q3 2024, an estimated $662.
  • Abich Financial Wealth Management first reported a position in Haemonetics in Q2 2024 and held it in 1 quarter.
  • Abich Financial Wealth Management's Haemonetics position peaked at $662 in Q2 2024.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.